Glucocorticoids in palliative medicine: is osteoporosis a problem?

Abstract

Get full access to this article

View all access options for this article.

References

Compston J . Prevention and treatment of osteoporosis. Clinical guidelines and new evidence. J R Coll Phys Lond 2000; 34: 518–521.

Reid IR . Glucocorticoid osteoporosis – mechanisms and management. Eur J Endocrinol 1997; 137: 209–217.

Ratcliffe MA , Lanham SA , Reid DM , Dawson AA . Bone mineral density (BMD) in patients with lymphoma: the effects of chemotherapy, intermittent corticosteroids and premature menopause. Haematol Oncol 1992; 10: 181–187.

National Osteoporosis Society . Guidance on the prevention and management of corticosteroid induced osteoporosis. Bath: National Osteoporosis Society, 1998.

Hardy JR , Rees E , Ling J , Burman R , Feuer D , Broadley K , Stone P . A prospective survey of the use of dexamethasone on a palliative care unit. Palliat Med 2001; 15: 3–8.